Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease

High-risk neuroblastoma remains a profound clinical challenge that requires eradication of neuroblastoma cells from a variety of organ sites, including bone marrow, liver, and CNS, to achieve a cure. While preclinical modeling is a powerful tool for the development of novel cancer therapies, the lac...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahavi, Seyed M., Aletaha, Maryam, Farrokhi, Ali, Lorentzian, Amanda, Lange, Philipp F., Maxwell, Christopher A., Lim, Chinten James, Reid, Gregor S. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419036/
https://www.ncbi.nlm.nih.gov/pubmed/37569447
http://dx.doi.org/10.3390/ijms241512071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419036/
https://www.ncbi.nlm.nih.gov/pubmed/37569447
http://dx.doi.org/10.3390/ijms241512071

Ejemplares similares